Post-marketing biopharmaceutical evaluation of dipyrone tablets: reference, generic and similar medicines
DOI:
https://doi.org/10.22239/2317-269X.01768Keywords:
Dipyrone; Quality Control; Dissolution Profile; Analytical Method; ValidationAbstract
Introduction: Dipyrone is a potent analgesic and antipyretic registered in the Brazilian List of Essential Medicines. Furthermore, it is strategically indicated in special cases, such as the palliative treatment of dengue, chikungunya, zika and COVID-19. Post-marketing problems have been identified for this drug, such as quality non-conformities, resulting in frequent withdrawals of medicines containing dipyrone by Anvisa. Objective: To investigate the quality and pharmaceutical equivalence of dipyrone tablets (reference, generics and similar), commercially available in Salvador-Bahia. Method: An experimental study was carried out using methodologies described in the Brazilian Pharmacopoeia 6th edition monograph of sodium dipyrone tablets. Three different brands were analyzed (one generic, two similar and one reference), all collected in Salvador-Bahia. In addition, an alternative analytical method by UV spectrophotometry was developed for the analysis of sodium dipyrone tablets, validated based on RDC No. 166/17. Results: The reference, generic and similar sodium dipyrone tablets met the requirements for identification and characteristics tests. A similar drug sample did not meet the dissolution test and only two generic samples were satisfactory for interchangeability. The assay pharmacopoeial method for dipyrone sodium tablets showed problems related to the analyst’s subjectivity and method uncertainty. The proposed alternative method proved to be selective, linear, precise, accurate, and robust, and indicated for the quantification of dipyrone in tablets. Conclusions: From the results obtained, it was observed that post-marketing monitoring of medicines with a population high consumption pattern, such as dipyrone, can signal issues to be investigated by health surveillance, with the objective of supporting its mission that is to protect population’s health.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Health Surveillance under Debate: Society, Science & Technology (Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnología) – “Visa em Debate”
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
COPYRIGHT ALLOWANCE The author (s) hereinafter designated as the ASSIGNOR hereby assign and transfer, free of charge, the ownership of the copyrights related to this ARTICLE to the Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debate, represented by FUNDAÇÃO OSWALDO CRUZ, established at Av. Brasil, nº 4365, Manguinhos, Rio de Janeiro, RJ, Brazil, CEP 21045-900, under the conditions set out below: (a) The terms and conditions set forth in this Agreement shall apply to the following: 1. The ASSIGNOR declares that they s(he) is (are) the author (s) and owner (s) of the copyrighted property of the ARTICLE submitted. 2. The ASSIGNOR declares that the ARTICLE does not infringe the copyrights and / or other property rights of third parties, that the disclosure of images (if any) has been authorized and that they s(he) assume(s) full moral and / or property liability for its content, before third parties. 3. THE ASSIGNOR assigns and transfers all copyrights relating to the ARTICLE to the ASSIGNEE, especially the rights of editing, publication, translation into another language and reproduction by any process or technique. The ASSIGNEE becomes the exclusive owner of the rights related to the ARTICLE, and any reproduction, totally or partially, is prohibited in any other means of publicity, printed or electronic, without prior written authorization from the ASSIGNEE. 4. The assignment is free and, therefore, there will be no remuneration for the use of the ARTICLE by the ASSIGNEE.
